Home > Income Statement > CONCORD BIOTECH

CONCORD BIOTECH
Consolidated Net Profit

    Back to Income Statement
CONCORD BIOTECH is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Best Quarterly Growth Small Cap Stocks
AD     Remove this Ad

CONCORD BIOTECH Last 5 Year Consolidated Net Profit History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Consolidated Net Profit ₹308 Cr₹240 Cr₹17 Cr₹235 Cr₹1,690 Cr

What is the latest Consolidated Net Profit of CONCORD BIOTECH ?

The latest Consolidated Net Profit ratio of CONCORD BIOTECH is ₹308 Cr based on Mar2025 Consolidated results.
Year Consolidated Net Profit
Mar2025₹308 Cr
Mar2024₹240 Cr
Mar2023₹17 Cr
Mar2022₹235 Cr
Mar2021₹1,690 Cr

How is Consolidated Net Profit of CONCORD BIOTECH Trending?

Years Consolidated Net Profit % Change
Mar2025 ₹308 Cr
28.33
Mar2024 ₹240 Cr
1,272.47
Mar2023 ₹17 Cr
-92.55
Mar2022 ₹235 Cr
-86.10
Mar2021 ₹1,690 Cr -

Compare Consolidated Net Profit of peers of CONCORD BIOTECH

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
CONCORD BIOTECH ₹10,675.5 Cr -1.7% -18.2% -39.9% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹414,713.0 Cr -1.4% -3.2% -0.5% Stock Analytics
DIVIS LABORATORIES ₹156,811.0 Cr -1.9% -8.7% 1.9% Stock Analytics
TORRENT PHARMACEUTICALS ₹139,052.0 Cr -3.5% -6.6% 30.6% Stock Analytics
DR REDDYS LABORATORIES ₹100,927.0 Cr -4% -8.3% 6.3% Stock Analytics
CIPLA ₹96,602.7 Cr -1.9% -11.9% -19% Stock Analytics


CONCORD BIOTECH Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
CONCORD BIOTECH

-1.7%

-18.2%

-39.9%

SENSEX

0.6%

-11.1%

-6.2%


You may also like the below Video Courses